A detailed history of Graham Capital Management, L.P. transactions in Genmab A/S stock. As of the latest transaction made, Graham Capital Management, L.P. holds 40,096 shares of GMAB stock, worth $827,982. This represents 0.02% of its overall portfolio holdings.

Number of Shares
40,096
Previous 23,691 69.25%
Holding current value
$827,982
Previous $595,000 64.2%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$23.84 - $28.48 $391,095 - $467,214
16,405 Added 69.25%
40,096 $977,000
Q2 2024

Aug 14, 2024

BUY
$25.13 - $30.27 $595,354 - $717,126
23,691 New
23,691 $595,000
Q4 2023

Feb 14, 2024

BUY
$27.94 - $35.44 $333,715 - $423,295
11,944 New
11,944 $380,000

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.6B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.